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doi:10.1Objectives: Optimal brain protection for aortic arch surgery remains unclear. This prospective study examined
neurocognitive outcomes in cardiac and thoracic aortic surgical patients, including a small cohort who under-
went selective cerebral perfusion.
Methods: Fifty-seven adult cardiac and thoracic aortic surgical patients underwent preoperative and postoper-
ative neurocognitive testing. Patients were divided into 3 groups. Group 1 patients underwent procedures with
cardiopulmonary bypass alone (n ¼ 24), group 2 patients with cardiopulmonary bypass and hypothermic circu-
latory arrest (n ¼ 23), and group 3 patients with cardiopulmonary bypass, hypothermic circulatory arrest, and
anterograde selective cerebral perfusion (n¼ 10). Changes in 14 neurocognitive test scores and 6 neurocognitive
domain scores (Attention, Speed, Language, Memory, Executive Function, andMotor Function) were evaluated.
Results: Multiple regression analyses examining the relationships of cardiopulmonary bypass time, hypother-
mic circulatory arrest time, and selective cerebral perfusion time with change in cognitive test performance
revealed that selective cerebral perfusion time (range, 39–83 minutes) was a significant predictor of decline
in performance on memory and language tests. Hypothermic circulatory arrest (range, 14–40 minutes) and
cardiopulmonary bypass (range, 70–369 minutes) times were unrelated to decline.
Conclusions: Complex thoracic aortic repairs requiring prolonged selective cerebral perfusion were associated
with decline in neurocognitive function. It is unclear whether the complexity of the repair necessitating
prolonged selective cerebral perfusion or the perfusion technique itself contributed to neurocognitive decline.
Prospective multicenter neurocognitive evaluations are necessary to assess the relative merits of current brain
protection strategies in thoracic aortic surgery. (J Thorac Cardiovasc Surg 2012;143:1205-12)The technique of thoracic aortic surgery was revolutionized
in 1975, when Griepp and colleagues1 introduced hypother-
mic circulatory arrest (HCA) to allow sufficient time to con-
duct surgical repairs in a bloodless field with acceptable to
excellent neurologic outcomes. As it came to be recognized
that the ‘‘safe’’ duration of HCA is limited, adjunct tech-
niques aimed at providing blood flow and metabolic support
to the brain were introduced to extend the time available for
complex aortic reconstructions. Retrograde cerebral perfu-
sion (RCP) is commonly used as a cerebral perfusion
adjunct jointly with HCA. Its efficacy for providing meta-
bolic support and improving neurologic outcomes remains
controversial, however, and some data suggest that RCP
has deleterious effects.2,3 For this reason, and as a result
of surgical innovation, antegrade selective cerebral
perfusion (SCP) is now used in many centers.e Departments of Anesthesiology and Cardiothoracic Surgery, Mount Sinai
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MIt is difficult to evaluate the relative neuroprotective effi-
cacies of these techniques, because the patient groups differ
with respect to multiple variables that potentially influence
outcome. The potentially confounding variables include the
following: preoperative factors, such as cognitive and neu-
rologic status, overall health, and atherosclerotic disease;
operative factors, such as emergency versus elective surgery
and surgical complexity; and postoperative factors, such as
neurologic morbidity (stroke and transient nonfocal neuro-
logic symptoms), nonneurologic morbidity, and mortality.
Moreover, there is marked variability among centers and
across time with respect to HCA, RCP, and SCP protocols.
Thus the existing literature consists mainly of retrospective
reports of gross neurologic outcomes from single-center co-
horts. The issue of the optimal methods of brain protection
during thoracic aortic surgery remains controversial.4-7
There have been few neurocognitive outcome studies ex-
amining the efficacy of intraoperative neuroprotection for
thoracic aortic surgery. We found that preoperative to post-
operative changes in memory and fine motor function were
worse in patients with HCA times of at least 25 minutes, rel-
ative to patients with shorter periods of HCA or with cardio-
pulmonary bypass (CPB) without HCA.8 Our subsequent
experience with RCP was associated with worse neurocog-
nitive outcome than was HCA alone, consistent with the
findings of other studies.9-11 In more recent years, wediovascular Surgery c Volume 143, Number 5 1205
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
FTT ¼ Finger Tapping Test
GPB ¼ Grooved Pegboard Test
HCA ¼ hypothermic circulatory arrest
HVLT-R¼ HopkinsVerbal Learning Test–Revised
RCP ¼ retrograde cerebral perfusion
SCP ¼ selective cerebral perfusion
TMT-A ¼ Trail Making Test A
TMT-B ¼ Trail Making Test B
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Mhave used SCP as the primary adjunct perfusion technique.
In this prospective study, we sought to evaluate further the
roles of HCA and SCP as predictors of preoperative to
postoperative cognitive decline.
MATERIALS AND METHODS
Patients
The study protocol was approved by the institutional review board.
Adult patients undergoing nonemergency cardiac or proximal aortic sur-
gery with CPB or thoracic aortic surgery with HCA between February
28, 2002, and June 16, 2008, were recruited into the study after providing
informed consent. Patients were divided into 3 groups. Group 1 patients un-
derwent coronary artery and cardiac valve procedures with CPB. Group 2
patients underwent thoracic aortic procedures with CPB and at least 1
period of HCA. Finally, group 3 patients underwent thoracic aortic proce-
dures with CPB, HCA, and at least 1 period of SCP.
Anesthesia and Monitoring
General anesthesia was induced with a hypnotic agent (etomidate, pro-
pofol) and supplemented with an opioid analgesic (fentanyl, sufentanil)
and a benzodiazepine (midazolam hydrochloride). Maintenance consisted
of isoflurane (0.6–1.5% end-tidal concentration), fentanyl, neuromuscular
blockers, and midazolam. All patients had mechanical ventilation with
a fraction of inspired oxygen of 1.0 to maintain the PaCO2 at 35 to 45
mm Hg.
The following monitors were placed: a radial arterial catheter, a pulmo-
nary arterial catheter, and temperature monitoring of the urinary bladder
catheter and the esophagus or nasopharynx. For HCA, a 20-gauge jugular
bulb catheter for intermittent sampling of jugular venous blood was placed
and confirmed by baseline jugular bulb venous saturation measurement.
Patients enrolled during the later years of the series underwent near-
infrared spectroscopic monitoring of transcranial cerebral oxygenation
and bispectral index monitoring.
Surgical and Perfusion Techniques
All patients underwent midline sternotomy. All patients undergoing
HCA had direct right axillary cannulation or end-to-side graft anastomosis
for CPB arterial inflow. Antegrade crystalloid or blood cardioplegia was
used every 20 to 30 minutes, either through an aortic root cannula or di-
rectly into the coronary ostia, and the left ventricle was vented. In patients
who did not undergo HCA, operations were performed with standard CPB
at mild to moderate hypothermia (28C–35C).
The techniques of HCAwere consistent throughout the duration of the
study and have been described in detail previously.12 Briefly, cooling dur-
ing CPB was performed until a core temperature of 12C to 15C, as1206 The Journal of Thoracic and Cardiovascular Surmeasured by a urinary bladder thermistor, was achieved. Alpha-stat pH
management was used, and cooling times of 45 minutes or longer were
generally required. Cooling was continued until jugular venous saturation
exceeded 95% in most cases and 90% in all. The head was packed in ice
before commencement of HCA for intervals expected to exceed 20 min-
utes. All patients undergoing HCAwere administered 30 mg/kg of methyl-
prednisolone before CPB. In patients with combined HCA and SCP times
exceeding 30 minutes, tapering doses of glucocorticoids were continued in
the intensive care unit for 48 hours.
In repairs involving the transverse aortic arch, the brachiocephalic ves-
sels were anastomosed to a trifurcated graft during a brief period of HCA.13
The proximal end of the trifurcated graft was then clamped, and SCP was
instituted through the right axillary cannula. We used alpha-stat manage-
ment, perfusate temperatures between 15C and 20C, hematocrit of
20% to 30%, and flows of approximately 10 mL/(kg/min) titrated to main-
tain a mean arterial pressure of 40 to 60 mm Hg. Adequacy of cerebral
oxygenation was confirmed by near-infrared spectroscopy and cerebral
oximetry in the later years of the series, although no specific criteria
were set.
On completion of the HCA and SCP portions of the procedures, gradual
systemic rewarmingwas carried out bymeans of CPB, limiting the gradient
between perfusate and urinary bladder temperature to less than 10C, with
a maximum perfusate temperature of 37C. Rewarming was discontinued
once an esophageal temperature of 35C to 37C and a urinary bladder
temperature of 32C to 35C had been achieved.
CPB time was defined as the cumulative time on full-body CPB, exclu-
sive of HCA or SCP. HCA time was defined as the cumulative time on full-
body circulatory arrest, exclusive of SCP. Brain perfusion time was defined
as the cumulative time on full-body CPB and SCP, which was equivalent to
CPB time for groups 1 and 2. CPB onset-to-offset time was defined as the
cumulative time from initiation of CPB toweaning fromCPB, regardless of
whether HCA or SCP was used within that interval. Surgical time was
defined as the time from incision to closure.
Neurocognitive Testing
Neurocognitive testing was performed preoperatively at preadmission
testing and postoperatively when patients returned to the hospital for surgi-
cal follow-up visit. The neurocognitive test battery consisted of 8 tests
yielding 14 test scores that assessed 6 domains of function, as summarized
in Table 1. The tests used were as follows: Wechsler Memory Scale III
Digit Span subtest (Psychological Corporation, New York, NY); Trail
Making Test (TMT-A and TMT-B; Neuropsychology Press, Tuscon,
Ariz); Symbol Digit Modalities Test, oral version (Western Psychological
Services, Los Angeles, Calif); Boston Naming Test–15 item version14;
Hopkins Verbal Learning Test–Revised (HVLT-R; Psychological Assess-
ment Resources, Inc, Odessa Fla); Stroop Color and Word Test (Stoelting
Co, Wood Dale, Ill); Finger Tapping Test (FTT; Psychological Assessment
Resources); and Grooved Pegboard Test (GPB; Psychological Assessment
Resources). Alternate forms of the HVLT-R and Boston Naming Test–15
item version were administered across the preoperative and postoperative
test sessions in a counterbalanced fashion. Only the dominant hand was
tested with the FTT and GPB.
Statistical Methods
The initial step in analyzing the neurocognitive test data was to convert
raw test scores to z scores. The normalized z score reflects where an ob-
served raw data point stands in relation to a reference group, allowing
for comparison across tests. For the purpose of standardization, we chose
the group of patients who underwent preoperative neurocognitive testing
and subsequent surgical procedures with CPB only as the reference group.
The difference between preoperative and postoperative z scores was then
computed for each test measure and each patient. Logarithmic transforma-
tion was performed on the time-related tests (TMT-A, TMT-B, and GPB) to
improve normality of the data. Because higher scores reflect poorergery c May 2012
TABLE 1. Neurocognitive battery assessing 6 domains of function
Test Test score
Attention
Wechsler Memory Scale III
Digit Span subtest
Digits Forward
Digits Backward
Digit Span
Processing speed
The Trail Making Test (TMT) Trail Making Test, Part A (TMT-A)
Trail Making Test, Part B (TMT-B)
The Symbol Digit Modalities
Test, oral version
SDMT
Language
Boston Naming Test—15
item version
BNT-15
Memory
Hopkins Verbal Learning
Test—Revised (HVLT-R)
HVLT-R Total Recall
HVLT-R Delayed Recall
HVLT-R Retention
HVLT-R Recognition
Executive function
Stroop Color and Word Test Stroop Interference (Stroop)
Motor function
Finger Tapping Test FTT
Grooved Pegboard Test GPB
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operative scores to ensure that negative difference scores would reflect a de-
cline in function for all measures.
To reduce the number of statistical analyses and decrease the risk of type
I error, we classified the 14 test scores into 6 domains: Attention, Process-
ing Speed, Language, Memory, Executive Function, and Motor Function.
Cluster analysis was used to confirm our conceptual grouping of the neuro-
cognitive tests by the variable cluster analysis (VARCLUS) procedure in
the SAS 9.1.3 statistical analysis software package (SAS Institute, Inc,
Cary, NC). This procedure uses iterative splitting (until a stopping criterion
is met) and factor analysis methods to divide a set of variables into nonover-
lapping subgroups. Because the VARCLUS procedure used for variable
cluster analysis removes subjects with incomplete data, and the HVLT-R
Retention, FTT, and GPB variables had greater than 15% missing data,
we excluded those variables from the cluster analysis. Complete preopera-
tive neurocognitive test data were available for 83 patients on 11 of the 14
neurocognitive test scores. After controlling for age and education, cluster
analysis yielded 5 clusters: Attention (Digits Forward, Digits Backward,
Digit Span), Processing Speed (TMT-A, TMT-B, and Symbol Digit Modal-
ities Test, oral version), Language (Boston Naming Test–15 item version),
Memory (HVLT-R Total Recall, HVLT-R Delayed Recall, and HVLT-R
Recognition), and Executive Function (Stroop). The proportion of variation
explained by these five clusters was 78%. We then assigned the HVLT-R
Retention variable to the Memory domain and the FTT and GPB variables
to the Motor Function domain. Finally, a composite score for each domain
for each patient was created by averaging the difference in z scores for the
variables in the cluster.
Statistical analyses were carried out using the SAS statistical software
package (version 9.1.3). For group comparisons, c2 tests were used for bi-
nary categoric variables, Students t tests or analysis of variance (allowing
heterogeneous variance across the groups) were used for normally distrib-
uted continuous variables, and nonparametric Kruskal-Wallis tests were
used for nonnormally distributed continuous variables.The Journal of Thoracic and CarMultiple linear regression analysis was used to model the associations
between the 3 types of perfusion and arrest times (CPB, HCA, and SCP)
and each of the neurocognitive test scores and domain scores, independent
of group assignment. The analyses assumed that the practice effects of the
tests were independent of the perfusion and arrest times. The models ad-
justed for preoperative neurocognitive scores and number of days since sur-
gery. Because of the small sample size, we chose not to adjust for age and
education level, assuming that the effects of these variables should be re-
flected in the baseline test scores. The models also adjusted for use of
HCA or SCP as binary variables (present or absent). To explore the possi-
bility of nonlinear relationships between CPB, HCA, and SCP times and
postoperative neurocognitive performance, a quadratic polynomial term
for CPB, HCA, and SCP times was tested for statistical significance.
Two-way interactions among use of HCA or SCP and perfusion and arrest
times were also tested.
To examine further the association between SCP time and neurocogni-
tive decline, we performed propensity score analysis that matched 10 pa-
tients from the HCA group with 10 from the SCP group. We used the
sampling with replacement technique to test the effects of SCP when the
matched pairs had similar brain perfusion time and HCA time. From the
sample of SCP group and HCA group subjects, a logistic regression was
performed to predict the probability (propensity score) of SCP group mem-
bership by using age, education, brain perfusion time, and HCA time as
predictors. The balance of the covariates (age, education, time of postoper-
ative testing, baseline neurocognitive domain z scores, brain perfusion
time, and HCA time) between the resulting matched pairs were compared
with t tests, and all differences were nonsignificant. In the next step, we re-
peated themultiple regression analysis for SCP time, adjusting for SCP use,
preoperative neurocognitive scores, and time of postoperative testing.RESULTS
Demographic Characteristics
A total of 178 cardiac and thoracic aortic surgical patients
underwent preoperative neuropsychologic testing: 88
(49.4%) in group 1, 61 (34.3%) in group 2, and 29
(16.3%) in group 3. Fifty-seven of those patients (32%) un-
derwent postoperative neuropsychologic testing at the out-
patient follow-up visit: 24 (42.1%) in group 1, 23 (40.4%)
in group 2, and 10 (17.5%) in group 3. The return rates for
postoperative neuropsychologic testing were 27%, 38%,
and 34% for groups 1, 2, and 3, respectively (P¼ .34). Post-
operative testing occurred 15 to 233 days (median, 44 days)
after surgery.
Of the 121 patients unavailable for follow-up, 3 (0, 2, and
1 for groups 1 through 3, respectively) died before hospital
discharge, 2 (0, 1, and 1) had strokes, and 9 (4, 3, and 2) had
medical complications necessitating their discharge to other
facilities (rehabilitation, acute care, or skilled nursing
facilities). Relative to patients who were unavailable for
follow-up (n ¼ 121), patients who underwent postoperative
neuropsychologic testing (n ¼ 57) were on average 5 years
younger (58 years vs 63 years; P¼ .03). They did not differ
with respect to level of education (P ¼ .97) or postsurgical
hospital stay (P ¼ .30).
The surgical procedures of patients in group 1 (n ¼ 24)
were single valve repairs (n ¼ 11), multiple valve repairs
(n ¼ 6), coronary artery bypass grafting (CABG; n ¼ 2),
CABG and valve repair (n ¼ 2), and ascending aorticdiovascular Surgery c Volume 143, Number 5 1207
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Mrepairs (n¼ 3). The surgical procedures of patients in group
2 (n¼ 23) were ascending aortic repairs (n¼ 13), ascending
aortic repairs with CABG (n ¼ 5), ascending aortic repairs
with mitral valve repair (n ¼ 1), ascending aortic repairs
with CABG and aortic valve repair (n ¼ 2), hemiarch re-
placement with aortic valve repair (n ¼ 1), and aortic arch
repair (n ¼ 1). The surgical procedures of patients in group
3 (n ¼ 10) were aortic arch replacement (n ¼ 8), ascending
aortic repair (n ¼ 1), and thoracoabdominal aortic repair
(n ¼ 1).Group Comparisons
Table 2 presents the characteristics of patients who un-
derwent both preoperative and postoperative neurocogni-
tive testing. The treatment groups were similar with
respect to age and education. Group 1 had significantly
more men than did group 3. The groups differed with re-
spect to hospital stay and time to postoperative testing,
with group 1 having significantly shorter intervals from sur-
gery to hospital discharge and from surgery to postoperative
testing. Duration and complexity of surgery, as assessed by
surgical duration and CPB onset-to-offset time, was signif-
icantly greater in groups 2 and 3 relative to group 1. Group 3
underwent significantly longer intervals of HCA than did
group 2. Total brain perfusion time was not significantly
different between groups 2 and 3.
Table 3 summarizes the raw preoperative and postopera-
tive test scores and z score differences. Overall, the 3 groups
differed on 3 of the 14 difference scores (TMT-B, HVLT-RTABLE 2. Group characteristics
Variable
Group 1, CPB
only (N ¼ 24)
Group
(
Age (y, mean  SD) 54.7  11.6 61
Education (y, mean  SD) 15.6  2.7 1
Education>12 y (%) 71%
Sex (% male) 79%
Stay (d, median and range) 6 (4–9) 8
Postoperative testing (d, median
and range)
39 (22–233) 50
CPB time (min, median and range){ 170 (70-307) 247
HCA time (min, median and range)** — 21
SCP time (min, median and range) —
Brain perfusion time (min, median
and range)yy
170 (70–307) 247
CPB onset-to-offset time (min,
median and range)zz
170 (70–307) 270
Surgical time (min, median and
range)xx
320 (194–451) 443
CPB, Cardiopulmonary bypass; HCA, hypothermic cardiac arrest; SCP, selective cerebral p
zGroup 3 differed significantly from group 1 (P< .05). xP value obtained with Wilco
{Cardiopulmonary bypass time is exclusive of hypothermic cardiac arrest and/or selective
pothermic circulatory arrest time is exclusive of selective cerebral perfusion time. yyBrain p
perfusion time, exclusive of hypothermic circulatory arrest. zzCardiopulmonary bypass ons
time is the time from incision to closure.
1208 The Journal of Thoracic and Cardiovascular SurTotal Recall, and FTT), with group 3 performing signifi-
cantly worse than group 2.Relationships of Perfusion and Arrest Times to
Neurocognitive Outcomes
Table 4 presents the results of multiple regression analyses
examining the relationships of CPB, HCA, and SCP times
(independent of group assignment) with the 6 neurocognitive
domain scores after adjustment for potential confounders.
The results indicate that SCP time (range, 39–83 minutes)
was a significant predictor of decline in the domains ofMem-
ory and Language. HCA time (range, 14–40minutes)was not
a significant predictor of decline in any domain, and therewas
no significant interaction between HCA time and SCP use.
CPB time (range, 70–369 minutes) was not a significant pre-
dictor of decline in any domain, and there was no significant
interaction between CPB time and HCA use or SCP use. As
a sensitivity analysis, the propensity score analysis (Table 4)
that used 10 matched pairs from the SCP and HCA groups
confirmed a significant association between SCP time and de-
cline in language (P ¼ .002). The effect of SCP on the
memory decline trended in the same direction as that seen
from the traditional regression analysis, with a P value of
.063 (Table 4). The lack of statistical significance could be
the result of low study power, with only 10 SCP matched
pairs.
Figure 1 presents the relationships between SCP time and
the neurocognitive domain scores. The correlations be-
tween SCP time and Memory and Language domain scores2, CPBþHCA
N ¼ 23)
Group 3, CPBþHCAþSCP
(N ¼ 10) P value
.6  15.9 57.3  15.9 .25*
4.6  2.5 13.5  2.1 .09*
65% 40% .23y
74% 40% .07y,z
(5–25) 8 (6–30) <.01x,k
(15-132) 48 (31–66) .038x,k
(143-369) 120.5 (83–237) <.01x,k,#
(14–31) 30 (14–40) .02x
— 68.5 (39–83)
(143–369) 198 (128–284) .01x,k
(171–390) 232 (162–309) <.01z,x,k
(329–713) 494 (401–660) <.01z,x,k
erfusion. *P value obtained with analysis of variance. yP value obtained with c2 test.
xon/Kruskal-Wallis test. kGroup 2 differed significantly from group 1 (P< .05).
cerebral perfusion time. #Group 3 differed significantly from group 2 (P<.05). **Hy-
erfusion time is the cumulative time of cardiopulmonary bypass and selective cerebral
et-to-offset is the time from cardiopulmonary bypass initiation to weaning. xxSurgical
gery c May 2012
TABLE 3. Raw preoperative and postoperative neurocognitive test scores and z score differences by group
Test
Group 1 CPB
only (N ¼ 24)
Group 2 CPBþHCA
(N ¼ 23)
Group 3 CPBþHCAþSCP
(N ¼ 10) P value
Digits Forward .870
Preoperative 10.67  2.44 9.26  2.22 9.60  2.07
Postoperative 10.83  2.75 9.57  1.95 9.60  1.78
Difference in z score 0.08  0.75 0.14  0.80 0.00  0.65
Digits Backward .397
Preoperative 7.25  2.88 6.04  1.69 6.10  2.77
Postoperative 7.46  3.11 6.04  1.92 5.50  2.64
Difference in z score 0.08  0.65 0.00  0.64 0.22  0.56
Digit Span .343
Preoperative 17.92  4.97 15.30  3.48 15.70  4.55
Postoperative 18.29  5.46 15.61  3.31 15.10  3.84
Difference in z score 0.09  0.64 0.07  0.52 0.14  0.38
TMT-A* .388
Preoperative 24.50 (21-30) 32 (25–41) 31.5 (29–37)
Postoperative 25.0 (21–30) 30 (27–49) 32.0 (21–39)
Difference in z score 0.00 (0.40 to 0.32) 0.27 (0.55 to 0.12) 0.14 (0.60 to 0.18)
TMT-B* .032y,z,x
Preoperative 58 (47–78) 85 (68–142) 86 (59–86)
Postoperative 60 (40–72) 88 (51–107) 91.5 (56–163)
Difference in z score 0.14 (0.11 to 0.38) 0.20 (0.21 to 0.65) 0.19 (0.41 to 0.03)
SDMT .482
Preoperative 48.83  12.12 46.05  10.78 44.89  8.95
Postoperative 51.71  14.07 46.21  13.19 44.80  8.82
Difference in z score 0.22  0.7 0.01  0.49 0.02  0.30
BNT-15 .172
Preoperative 13.43  2.02 13.09  1.50 13.80  1.03
Postoperative 13.78  1.62 13.83  1.47 13.60  1.17
Difference in z score 0.17  0.66 0.35  0.50 0.09  0.70
HVLT-R Total Recall .024k,{
Preoperative 22.83  4.80 19.83  4.51 22.20  6.07
Postoperative 22.67  4.48 21.61  5.80 19.10  5.17
Difference in z score 0.03  0.83 0.35  0.81 0.61  0.98
HVLT-R Delayed Recall .931
Preoperative 7.75  2.80 6.87  2.42 7.90  2.28
Postoperative 7.83  2.12 7.00  2.63 7.60  5.38
Difference in z score 0.02  0.85 0.05  0.87 0.11  1.34
HVLT-R Retention .666
Preoperative 87.38  17.58 83.28  21.05 111.63  51.25
Postoperative 86.89  15.44 83.67  24.42 90.14  37.71
Difference in z score 0.00  0.48 0.01  0.71 0.45  1.28
HVLT-R Recognition .388
Preoperative 10.00  1.91 10.39  1.23 9.80  1.48
Postoperative 10.42  1.50 10.09  2.37 10.50  2.17
Difference in z score 0.20  0.79 0.15  1.23 0.34  0.85
Stroop .799
Preoperative 1.35  5.51 2.14  4.89 3.25  6.66
Postoperative 1.38  6.73 0.75  5.57 2.85  6.52
Difference in z score 0.00  0.70 0.14  0.71 0.05  0.66
FTT .019z,x,k
Preoperative 49.76  10.12 46.19  12.75 45.70  13.21
Postoperative 50.18  12.04 44.64  12.47 42.20  13.41
Difference in z score 0.15  0.33 0.12  1.03 0.32  0.63
(Continued)
Uysal et al Perioperative Management
The Journal of Thoracic and Cardiovascular Surgery c Volume 143, Number 5 1209
P
M
TABLE 3. Continued
Test
Group 1 CPB
only (N ¼ 24)
Group 2 CPBþHCA
(N ¼ 23)
Group 3 CPBþHCAþSCP
(N ¼ 10) P value
GPB* .499
Preoperative 69 (66–77) 83.5 (74–101) 79 (72–88)
Postoperative 69 (63–76) 80.5 (74–116) 75 (63–105)
Difference in z score 0.24 (0.19 to 0.61) 0.13 (0.35 to 0.55) 0.28 (0.45 to 0.38)
Tests are as listed in Table 1.CPB, Cardiopulmonary bypass;HCA, hypothermic cardiac arrest; SCP, selective cerebral perfusion. For normally distributed test scores, mean SD
is given. For nonnormally distributed test scores (TMT-A, TMT-B, and GPB), median with interquartile range is given. *For TMT-A, TMT-B, and GPB, the signs are reversed
from the original scales, to reflect that longer time is associated with greater decline in cognitive function. yP value obtained with Wilcoxon/Kruskal-Wallis Test. zThe selective
cerebral perfusion group differed significantly from the cardiopulmonary bypass group (P<.05). xThe selective cerebral perfusion group differed significantly from the hypo-
thermic circulatory arrest group (P<.05). kP value obtained with analysis of variance. {The hypothermic circulatory arrest group differed significantly from the cardiopulmonary
bypass group (P<.05).
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showed no statistically significant relationships between
SCP time and the other domain scores; however, the corre-
lations between SCP time and Attention, Executive Func-
tion, and Motor Function domain scores were negative
and in the range of0.3 to0.5, which is considered to be
of moderate size for data of this nature.
DISCUSSION
This study examined neurocognitive function prospec-
tively in cardiac and thoracic aortic surgical patients who
underwent procedures with CPB alone, CPB plus HCA,
or CPB plus HCA and SCP. In group comparison analyses,
we found that patients who underwent procedures with SCP
had significantly greater declines on 3 of 14 test scores.
Multiple regression analyses revealed that SCP duration
(range, 39–83 minutes) was a significant predictor of de-
cline in performance on Memory and Language domain
tests. HCA duration (range, 14–40 minutes) was unrelated
to neurocognitive decline across all patients who underwent
HCA (independent of group assignment). CPB duration
(range, 70–369 minutes) across the entire sample of patients
(independent of group assignment) was also unrelated to
neurocognitive decline.
Other neurocognitive outcome studies have reported
mixed results in patients undergoing thoracic aortic proce-
dures with SCP. A study of 22 patients who underwent aor-
tic arch repair with SCP at moderate hypothermia (26C)
found no significant declines in test scores.15 SvenssonTABLE 4. Multiple regression analyses of the relationships of cardiopul
cerebral perfusion times with neurocognitive domain scores, adjusting for
Outcome measure
CPB time HCA time
b* SE* P value b* SE* P value
Attention 0.0009 0.0012 .467 0.0140 0.0156 .373
Speed 0.0014 0.0010 .166 0.0056 0.0133 .674
Language 0.0010 0.0012 .392 0.0018 0.0150 .232
Memory 0.0008 0.0013 .530 0.0132 0.0165 .427
Executive 0.0001 0.0017 .959 0.0101 0.0215 .640
Motor 0.0022 0.0012 .063 0.0178 0.0156 .261
*The b coefficient and its SE were derived from linear regression model.
1210 The Journal of Thoracic and Cardiovascular Surand colleagues11 compared neurocognitive outcomes in 30
aortic arch surgical patients cooled to less than 20C and
randomly assigned to HCA, HCA plus RCP, or HCA plus
SCP and found that mean postoperative test scores were sig-
nificantly worse in the SCP group than in the HCA group. A
study performed by Pacini and colleagues16 compared 16
patients who underwent aortic arch surgery with SCP with
14 patients who underwent elective CABG. They found no
significant neurocognitive test score differences between
the 2 groups or within the SCP group across 3 evaluations
(preoperative, 1 postoperative week, and 6 postoperative
months). By means of diffusion-weighted magnetic reso-
nance imaging, they found that SCPwas associated with dif-
fuse vasogenic cerebral edema at 1 postoperative week and
that this effect persisted in the temporal lobe at 6 postoper-
ative months. This finding is notable because it is consistent
with our finding of decline in performance on Memory and
Language domain tests, because neurocognitive profiles
characterized by episodic memory and language deficits
against a background of otherwise normal cognitive function
implicate temporal lobe pathology.
Our finding that HCA duration (range, 14–40 minutes)
was unrelated to neurocognitive decline contrasts with our
previous findings, in which prolonged HCA durations
(25 minutes) were associated with declines in memory
and finemotor function.8 Our institutional approach to brain
protection has evolved significantly since our 1999 publica-
tion, in that HCA periods overall became much shorter as
SCP was introduced into clinical practice.monary bypass, hypothermic cardiopulmonary bypass, and selective
potential confounders
SCP time SCP time (propensity score analysis)
b* SE* P value b* SE* P value
0.0070 0.0105 .509 0.0089 0.0094 .360
0.0090 0.0092 .335 0.0117 0.0103 .274
0.0277 0.0105 .011 0.0356 0.0092 .002
0.0349 0.0115 .004 0.0274 0.0137 .063
0.0093 0.0142 .516 0.0096 0.0150 .534
0.0061 0.0117 .604 0.0185 0.0103 .096
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FIGURE 1. The relationships between selective cerebral perfusion (SCP) duration and neurocognitive domain scores (differences in z scores), with Pearson
correlation coefficients.
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MThe nature of complex aortic repairs is that they are
performed in referral centers, drawing patients from large
geographic regions. This poses significant obstacles to neu-
rocognitive outcomes research because, after hospital dis-
charge, many patients are physically inaccessible for
follow-up testing, resulting in high attrition. Those patients
who do return to the center after hospital discharge typically
are only available for postoperative neurocognitive testing
on the day that they are scheduled for follow-up with their
surgeons. We believe that such limitations are common in
long-term neuropsychologic testing studies of surgical pa-
tients at referral centers. Furthermore, it is impractical to
generalize findings across small studies from multiple cen-
ters or to perform meta-analytic studies because of varia-
tions in the ways that HCA, RCP, and SCP are practiced
and also in the methods of neurocognitive evaluation.
Although it is reasonable to expect poorer neurocognitive
outcomes in patients undergoing extensive reconstructive
surgery of the aortic arch requiring SCP, the findings of
this study are limited by the small postoperative sample
size and the wide variation in timing of postoperative test-
ing. Despite the small sample size, however, the propensity
score analysis did confirm the association between SCPThe Journal of Thoracic and Carduration and decline in Language domain (naming) test
scores. A similar trend of an effect of SCP on decline in
Memory domain scores did not retain statistical signifi-
cance (P ¼ .06), however, and the findings regarding mem-
ory decline thus should be considered less definitive. We
also acknowledge that the number of covariates collected
in this study is limited. For example, ranges of hemoglobin
concentration, perfusion pressures, and flow rates during
CPB and SCP were not investigated. Despite these limita-
tions, the traditional regression analysis and the confirma-
tory propensity score analysis were concordant. These
data indicate that future investigations with larger patient
samples and more covariates are warranted.
Neurocognitive outcome studies are essential in evaluat-
ing the efficacy of neuroprotection strategies for thoracic
aortic surgery. We present these preliminary data to dem-
onstrate that SCP did not eliminate the neurocognitive de-
cline that has been previously identified as a problem in
complex aortic arch repairs. Prospective multicenter inves-
tigation that uses remote, Internet-based neurocognitive
testing, with uniform test selection and test timing, is
the most promising approach for such studies. We have
previously demonstrated that studying neurocognitivediovascular Surgery c Volume 143, Number 5 1211
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Moutcomes with such technology is practical in this patient
population.17
In conclusion, our institution changed its clinical ap-
proach to brain protection in complex aortic repairs nearly
15 years ago in response to our clinical and laboratory find-
ings that prolonged HCA was associated with deleterious
cognitive outcomes. Our current data do not support the
principle that substitution for prolonged HCA with shorter
periods of HCA combined with SCP alleviates the problem
of cognitive dysfunction after complex aortic arch repairs.
Further research is required to validate these findings in
larger clinical studies.References
1. Griepp RB, Stinson EB, Hollingsworth JF, Buehler D. Prosthetic replacement of
the aortic arch. J Thorac Cardiovasc Surg. 1975;70:1051-63.
2. Reich DL, Uysal S, Ergin MA, Griepp RB. Retrograde cerebral perfusion as
a method of neuroprotection during thoracic aortic surgery. Ann Thorac Surg.
2001;72:1774-82.
3. Apostolakis E, Akinosoglou K. The methodologies of hypothermic circulatory
arrest and of antegrade and retrograde cerebral perfusion for aortic arch surgery.
Ann Thorac Cardiovasc Surg. 2008;14:138-48.
4. Gega A, Rizzo JA, Johnson MH, Tranquilli M, Farkas EA, Elefteriades JA.
Straight deep hypothermic arrest: experience in 394 patients supports its effec-
tiveness as a sole means of brain preservation. Ann Thorac Surg. 2007;84:759-67.
5. Bachet J. What is the best method for brain protection in surgery of the aortic
arch? Selective antegrade cerebral perfusion. Cardiol Clin. 2010;28:389-401.
6. Elefteriades JA. What is the best method for brain protection in surgery of the
aortic arch? Straight DHCA. Cardiol Clin. 2010;28:381-7.1212 The Journal of Thoracic and Cardiovascular Sur7. Ueda Y.What is the best method for brain protection in surgery of the aortic arch?
Retrograde cerebral perfusion. Cardiol Clin. 2010;28:371-9.
8. Reich DL, Uysal S, Sliwinski M, Ergin MA, Kahn RA, Konstadt SN, et al. Neu-
ropsychologic outcome after deep hypothermic circulatory arrest in adults. J
Thorac Cardiovasc Surg. 1999;117:156-63.
9. Reich DL, Uysal S, Ergin MA, Bodian CA, Hossain S, Griepp RB. Retrograde
cerebral perfusion during thoracic aortic surgery and late neuropsychological
dysfunction. Eur J Cardiothorac Surg. 2001;19:594-600.
10. Harrington DK, Bonser M, Moss A, Heafield MT, Riddoch MJ, Bonser RS. Neu-
ropsychometric outcome following aortic arch surgery: a prospective random-
ized trial of retrograde cerebral perfusion. J Thorac Cardiovasc Surg. 2003;
126:638-44.
11. Svensson LG, Nadolny EM, Penney DL, Jacobson J, Kimmel WA, Entrup MH,
et al. Prospective randomized neurocognitive and S-100 study of hypothermic
circulatory arrest, retrograde brain perfusion, and antegrade brain perfusion for
aortic arch operations. Ann Thorac Surg. 2001;71:1905-12.
12. Etz CD, Homann TM, Rane N, Bodian CA, Di Luozzo G, Plestis KA, et al. Aortic
root reconstruction with a bioprosthetic valved conduit: a consecutive series of
275 procedures. J Thorac Cardiovasc Surg. 2007;133:1455-63.
13. Spielvogel D, Etz CD, Silovitz D, Lansman SL, Griepp RB. Aortic arch replace-
ment with a trifurcated graft. Ann Thorac Surg. 2007;83:S791-5; discussion
S824-31.
14. MackWJ, Freed DM,Williams BW, Henderson VW. Boston Naming Test: short-
ened versions for use in Alzheimer’s disease. J Gerontol. 1992;47:154-8.
15. €Ozatik MA, K€uc¸€uker SA, T€ul€uce H, Sartias¸ A, Sener E, Karakas¸ S, et al. Neuro-
cognitive functions after aortic arch repair with right brachial artery perfusion.
Ann Thorac Surg. 2004;78:591-5.
16. Pacini D, DiMarco L, Leone A, Tonon C, Pettinato C, Fonti C, et al. Cerebral
functions and metabolism after antegrade selective cerebral perfusion in aortic
arch surgery. Eur J Cardiothorac Surg. 2010;37:1322-31.
17. Uysal S, Mazzeffi M, Lin HM, Fischer GW, Griepp RB, Adams DH, et al.
Internet-based assessment of postoperative neurocognitive function in cardiac
and thoracic aortic surgery patients. J Thorac Cardiovasc Surg. 2011;141:
777-81.gery c May 2012
